Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Alterity Therapeutics ( (AU:ATH) ).
Alterity Therapeutics Limited announced the cessation of 35 million securities due to the expiry of options without exercise or conversion as of September 17, 2025. This cessation may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategy and future growth prospects.
More about Alterity Therapeutics
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapeutic products for neurodegenerative diseases.
YTD Price Performance: 20.0%
Average Trading Volume: 13,820,661
Technical Sentiment Signal: Sell
Current Market Cap: A$130.5M
See more data about ATH stock on TipRanks’ Stock Analysis page.